Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Douglas Shytle

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Geroscience|March 17, 2017
Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegenerationBethany Grimmig, Seol-Hee Kim, Kevin Nash, et al.
International Journal of Pharmaceutics|January 20, 2010
Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's diseaseAdam Smith, Brian Giunta, Paula C Bickford, et al.
Depression and Anxiety|November 5, 2002
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamineR Douglas Shytle, Archie A Silver, Kathy H Sheehan, et al.
Experimental Neurology|March 21, 2022
Autism, heparan sulfate and potential interventionsJacob Alexander, Gizem Keles, Jessica Killingsworth, et al.
Journal of Clinical Pharmacology|August 28, 2015
Addressing potential role of magnesium dyshomeostasis to improve treatment efficacy for epilepsy: A reexamination of the literatureKatie E Osborn, R Douglas Shytle, Alfred T Frontera, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary studyTony P George, Kristi A Sacco, Jennifer C Vessicchio, et al.
Neuroscience Letters|January 26, 2010
Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 miceBrian Giunta, Houyan Hou, Yuyan Zhu, et al.
Life Sciences|October 16, 2002
Nicotine's oxidative and antioxidant properties in CNSMary B Newman, Gary W Arendash, R Douglas Shytle, et al.
Journal of Neuroinflammation|September 27, 2008
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expressionKavon Rezai-Zadeh, Jared Ehrhart, Yun Bai, et al.
Cell Transplantation|May 29, 2019
Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen TherapyR Douglas Shytle, David J Eve, Soel-Hee Kim, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Geroscience|March 17, 2017
Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegenerationBethany Grimmig, Seol-Hee Kim, Kevin Nash, et al.
International Journal of Pharmaceutics|January 20, 2010
Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's diseaseAdam Smith, Brian Giunta, Paula C Bickford, et al.
Depression and Anxiety|November 5, 2002
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamineR Douglas Shytle, Archie A Silver, Kathy H Sheehan, et al.
Experimental Neurology|March 21, 2022
Autism, heparan sulfate and potential interventionsJacob Alexander, Gizem Keles, Jessica Killingsworth, et al.
Journal of Clinical Pharmacology|August 28, 2015
Addressing potential role of magnesium dyshomeostasis to improve treatment efficacy for epilepsy: A reexamination of the literatureKatie E Osborn, R Douglas Shytle, Alfred T Frontera, et al.
Journal of Clinical Psychopharmacology|May 16, 2008
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary studyTony P George, Kristi A Sacco, Jennifer C Vessicchio, et al.
Neuroscience Letters|January 26, 2010
Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 miceBrian Giunta, Houyan Hou, Yuyan Zhu, et al.
Life Sciences|October 16, 2002
Nicotine's oxidative and antioxidant properties in CNSMary B Newman, Gary W Arendash, R Douglas Shytle, et al.
Journal of Neuroinflammation|September 27, 2008
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expressionKavon Rezai-Zadeh, Jared Ehrhart, Yun Bai, et al.
Cell Transplantation|May 29, 2019
Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen TherapyR Douglas Shytle, David J Eve, Soel-Hee Kim, et al.
Pageof 5